Shenzhen, China

Jing Wu

This inventor holds 18 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Antenna Technology. Top assignees: Aac Technologies Pte. Ltd., Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd., Tencent Technology (Shenzhen) Company Limited. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Wu. Retrieved from https://idiyas.com/inventor/jing-wu-gp3ja7gi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 50.0

 

Average Co-Inventor Count = 1.7

ph-index = 1

Forward Citations = 34(Granted Patents)


Location History:

  • Guangdong, CN (2021)
  • Shenzhen, CN (2016 - 2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Multi-Target Tyrosine Kinase Inhibitor
Ice Cube Tray
Cushion
Mobile Terminal
Antenna Module
Dual-Band MIMO Antenna
Electronic Device
Pharmaceutical Composition
Immune Compound
Crystal Form
Performance Optimization
Two-Dimensional Barcode
18 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jing Wu

Introduction

Jing Wu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds with therapeutic potential. With a total of 18 patents to his name, Wu's work exemplifies the intersection of science and technology in addressing critical health challenges.

Latest Patents

One of Jing Wu's latest patents is a multi-target tyrosine kinase inhibitor. This invention relates to a compound that exhibits protein kinase inhibitory activity, as demonstrated in formula (I). The compound is metabolized into an active small molecule, td32-4, which effectively inhibits tumor growth in vivo, achieving notable anti-tumor effects. Compared to td32-4, this new compound shows significantly improved solubility and oral bioavailability, along with strong anti-tumor activity in animal experiments. The patent also details a synthetic method for the compound and its applications in the pharmaceutical field.

Career Highlights

Throughout his career, Jing Wu has worked with several notable companies, including Aac Technologies Pte. Ltd. and Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Jing Wu has collaborated with various professionals in his field, including Ke Hua and Tian Tang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jing Wu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in cancer treatment and other therapeutic areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…